Meta-analysis and systematic review of antibiotic trials. by Wilson, A, Bint, A, Glenny, A, Leibovici, L, Peto, T

Investigator-initiated randomized controlled trials in infectious diseases: better value for money for registration trials of new antimicrobials by Paul, M, Harbarth, S, Huttner, A, Thwaites, GE, Theuretzbacher, U, Bonten, MJM, Leibovici, L

Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study by Gomila A, Carratalà J, Eliakim-Raz N, Shaw E, Wiegand I, Vallejo-Torres L, Gorostiza A, Vigo JM, Morris S, Stoddart M, Grier S, Vank C, Cuperus N, van den Heuvel L, Vuong C, MacGowan A, Leibovici L, Addy I, Pujol M

Get full text

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. by Harris, P, McNamara, J, Lye, D, Davis, J, Bernard, L, Cheng, A, Doi, Y, Fowler, V, Kaye, K, Leibovici, L, Lipman, J, Llewelyn, M, Munoz-Price, S, Paul, M, Peleg, A, Rodríguez-Baño, J, Rogers, B, Seifert, H, Thamlikitkul, V, Thwaites, G, Tong, S, Turnidge, J, Utili, R, Webb, S, Paterson, D